We proposed that breast cancer cells with HER2 over-expression may be HER2-addicted, and thus repression of HER2 expression by E1A 1-80 is a potential mechanism for E1A 1-80-mediated killing of these cells [3]. The gene discussed is ERBB2; the disease is breast cancer.